Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				9218 NCT00212381

Last Modified: 9/3/2008 First Published: 4/13/2007


2.		Phase III Randomized Study of Diindolylmethane in Patients With Low-Grade Cervical Cytological Abnormalities

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				Not specified				Other				CRUK-CRISP-1 ISRCTN47437431, EU-20717, NCT00462813

Last Modified: 8/31/2007 First Published: 10/21/2006


3.		Phase I Randomized Study of Nutritional-Grade, Absorption-Enhanced Diindolylmethane (BR-DIM) in Healthy Volunteers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				18 to 70				NCI				KUMC-HSC-9139-3 HSC # 9139, NCT00392652

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute